Submissions from 2024
American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis and management of solid pancreatic masses: summary and recommendations., Jorge D Machicado, Sunil G Sheth, Jean M Chalhoub, Nauzer Forbes, Madhav Desai, Saowanee Ngamruengphong, Georgios I Papachristou, Vaibhav Sahai, Ibrahim Nassour, Wasif Abidi, Omeed Alipour, Stuart K Amateau, Nayantara Coelho-Prabhu, Natalie Cosgrove, Sherif E Elhanafi, Larissa L Fujii-Lau, Divyanshoo R Kohli, Neil B Marya, Swati Pawa, Wenly Ruan, Nikhil R Thiruvengadam, Nirav C Thosani, and Bashar J Qumseya
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial., Kenneth W Mahaffey, Katherine Tuttle, Mustafa Arici, Florian M M Baeres, George Bakris, David M Charytan, David Z I Cherney, Gil Chernin, Ricardo Correa-Rotter, Janusz Gumprecht, Thomas Idorn, Giuseppe Pugliese, Ida Kirstine Bull Rasmussen, Søren Rasmussen, Peter Rossing, Ekaterina Sokareva, Johannes F E Mann, Vlado Perkovic, and Richard Pratley
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial., Johannes F E Mann, Peter Rossing, George Bakris, Nicolas Belmar, Heidrun Bosch-Traberg, Robert Busch, David M Charytan, Samy Hadjadj, Pieter Gillard, José Luis Górriz, Thomas Idorn, Linong Ji, Kenneth W Mahaffey, Vlado Perkovic, Søren Rasmussen, Roland E Schmieder, Richard E Pratley, and Katherine Tuttle
The Performance of Critical Congenital Heart Disease Screening in Rural Versus Urban Locations in the Northwest United States., Brian S Marcus, Plicy Perez-Kersey, Ann B Lee, Richard A Jensen, Beth S Dullanty, Patrick R Parrish, Matthew V Park, William Tressel, Richard Kronmal, and Amy H Schultz
American Society for Gastrointestinal Endoscopy guideline on the role of therapeutic EUS in the management of biliary tract disorders: methodology and review of evidence., Neil B Marya, Swati Pawa, Nikhil R Thiruvengadam, Saowanee Ngamruengphong, Todd H Baron, Anthony Yuen Bun Teoh, Christopher K Bent, Wasif Abidi, Omeed Alipour, Stuart K Amateau, Madhav Desai, Jean M Chalhoub, Nayantara Coelho-Prabhu, Natalie Cosgrove, Sherif E Elhanafi, Nauzer Forbes, Larissa L Fujii-Lau, Divyanshoo R Kohli, Jorge D Machicado, Udayakumar Navaneethan, Wenly Ruan, Sunil G Sheth, Nirav C Thosani, and Bashar J Qumseya
Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial., Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, Parminder K Judge, Doreen Zhu, Emily Sammons, David Zi Cherney, Alfred K Cheung, Aldo P Maggioni, Masaomi Nangaku, Xavier Rossello, Katherine Tuttle, Katsuhito Ihara, Tomoko Iwata, Christoph Wanner, Jonathan Emberson, David Preiss, Martin J Landray, Colin Baigent FMedSci, Richard Haynes, and William G Herrington
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial., Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, Parminder K Judge, Doreen Zhu, Emily Sammons, David Z I Cherney, Alfred K Cheung, Aldo P Maggioni, Masaomi Nangaku, Xavier Rossello, Katherine R Tuttle, Katsuhito Ihara, Tomoko Iwata, Christoph Wanner, Jonathan Emberson, David Preiss, Martin J Landray, Colin Baigent, Richard Haynes, William G Herrington, and EMPA-KIDNEY Collaborative Group
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD., Kaitlin J Mayne, Natalie Staplin, David F Keane, Christoph Wanner, Susanne Brenner, Vladimir Cejka, Johannes Stegbauer, Parminder K Judge, David Preiss, Jonathan Emberson, Daniele Trinca, Rejive Dayanandan, Ryonfa Lee, John Nolan, Akiko Omata, Jennifer B Green, David Z I Cherney, Lai Seong Hooi, Roberto Pontremoli, Katherine Tuttle, Jennifer S Lees, Patrick B Mark, Simon J Davies, Sibylle J Hauske, Dominik Steubl, Martina Brückmann, Martin J Landray, Colin Baigent, Richard Haynes, William G Herrington, and EMPA-KIDNEY Collaborative Group
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD., Kaitlin J Mayne, Natalie Staplin, David F Keane, Christoph Wanner, Susanne Brenner, Vladimir Cejka, Johannes Stegbauer, Parminder K Judge, David Preiss, Jonathan Emberson, Daniele Trinca, Rejive Dayanandan, Ryonfa Lee, John Nolan, Akiko Omata, Jennifer B Green, David Z I Cherney, Lai Seong Hooi, Roberto Pontremoli, Katherine Tuttle, Jennifer S Lees, Patrick B Mark, Simon J Davies, Sibylle J Hauske, Dominik Steubl, Martina Brückmann, Martin J Landray, Colin Baigent, Richard Haynes, William G Herrington, and EMPA-KIDNEY Collaborative Group
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk., Rozalina G McCoy, Jeph Herrin, Kavya Sindhu Swarna, Yihong Deng, David M Kent, Joseph S Ross, Guillermo E Umpierrez, Rodolfo J Galindo, William H Crown, Bijan J Borah, Victor M Montori, Juan P Brito, Joshua J Neumiller, Mindy M Mickelson, and Eric C Polley
From Heart Failure to Heart Success - What's New for 2024, Deidre Mooney
“Heart failure death rates on the rise, but local specialists say there more to that”, Deidre Mooney
Sodium-glucose cotransporter 2 inhibitors and cardiovascular events among patients with type 2 diabetes and low-to-normal body mass index: a nationwide cohort study., Yuichiro Mori, Toshiaki Komura, Motohiko Adomi, Ryuichiro Yagi, Shingo Fukuma, Naoki Kondo, Motoko Yanagita, O Kenrik Duru, Katherine Tuttle, and Kosuke Inoue
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD., Sankar D Navaneethan, Nisha Bansal, Kerri L Cavanaugh, Alexander Chang, Susan Crowley, Cynthia Delgado, Michelle M Estrella, Cybele Ghossein, T Alp Ikizler, Holly Koncicki, Wendy St Peter, Katherine Tuttle, and Jeffrey William
Insulin Icodec., Matthew Nelson
Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis., Brendon L Neuen, Robert A Fletcher, Lauren Heath, Adam Perkovic, Muthiah Vaduganathan, Sunil Badve, Katherine Tuttle, Richard Pratley, Hertzel C Gerstein, Vlado Perkovic, and Hiddo J L Heerspink
Reframing Chronicity with Urgency in Chronic Kidney Disease Management., Brendon L Neuen, Katherine R Tuttle, George Bakris, and Muthiah Vaduganathan
Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease., Brendon L Neuen, Katherine Tuttle, and Muthiah Vaduganathan
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure., Jeremy Nicolarsen, James Mudd, and Andrew Coletti
A Case of Facial Nerve Injury Status Post Cerebral Dural Arterio-Venous Fistula Embolization., Anand S Patil and Kayli Gimarc
QI Blue Bands, Rebecca Penders
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE)., Pablo E Pergola, Michael Davidson, Camilla Jensen, Amir A Mohseni Zonoozi, Dominic S Raj, Philip Andreas Schytz, Katherine Tuttle, and Vlado Perkovic
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE)., Pablo E Pergola, Michael Davidson, Camilla Jensen, Amir A Mohseni Zonoozi, Dominic S Raj, Philip Andreas Schytz, Katherine Tuttle, and Vlado Perkovic
Semaglutide for Chronic Kidney Disease in Type 2 Diabetes. Reply., Vlado Perkovic, Katherine Tuttle, and Richard Pratley
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes., Vlado Perkovic, Katherine R Tuttle, Peter Rossing, Kenneth W Mahaffey, Johannes F E Mann, George Bakris, Florian M M Baeres, Thomas Idorn, Heidrun Bosch-Traberg, Nanna Leonora Lausvig, Richard Pratley, and FLOW Trial Committees and Investigators
The Importance of Networks and Relationships: Leveraging the Biocontainment Unit Leadership Workgroup for Special Pathogen Outbreak Response., Caroline C Persson, Christa Arguinchona, Sophia Y Shea, and Lauren M Sauer
Building a biocontainment unit: Infrastructure and organizational experiences of the 13 regional biocontainment units in the United States., Caroline Persson, Corri B Levine, Kara Marshall, Sophia Shea, Christa Arguinchona, Sharon Vanairsdale Carrasco, Lauren M Sauer, and Jocelyn J Herstein
Interrogating Tumor Structural Variation and Nongenic Dark Matter with Whole-Transcriptome Profiling, Brian Piening
American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of chronic pancreatitis: summary and recommendations., ASGE Standards of Practice Committee, Sunil G Sheth, Jorge D Machicado, Jean M Chalhoub, Christopher Forsmark, Nicholas Zyromski, Nirav C Thosani, Nikhil R Thiruvengadam, Wenly Ruan, Swati Pawa, Saowanee Ngamruengphong, Neil B Marya, Divyanshoo R Kohli, Larissa L Fujii-Lau, Nauzer Forbes, Sherif E Elhanafi, Madhav Desai, Natalie Cosgrove, Nayantara Coelho-Prabhu, Stuart K Amateau, Omeed Alipour, Wasif Abidi, Bashar J Qumseya, and ASGE Standards of Practice Committee Chair
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial., Richard E Pratley, Katherine Tuttle, Peter Rossing, Søren Rasmussen, Vlado Perkovic, Olav Wendelboe Nielsen, Johannes F E Mann, Richard J MacIsaac, Mikhail N Kosiborod, Zdravko Kamenov, Thomas Idorn, Marco Bo Hansen, Samy Hadjadj, George Bakris, Florian M M Baeres, and Kenneth W Mahaffey
Decrease in phase slip rates and phase cone structures during seizure evolution and epileptogenic activities derived from microgrid ECoG data., Ceon Ramon, Alexander Doud, and Mark D Holmes
Comparisons of healthcare personnel relating to awareness, concern, motivation, and behaviours of climate and health: A cross-sectional study., Teresa Rangel, Sarah E Johnson, Patricia Joubert, Rosemary Timmerman, Stephan Smith, Gale Springer, and Elizabeth Schenk
Factors associated with health personnel-chaplain interactions in the hospital setting: a cross-sectional survey study., Teresa Rangel, Gary Weisbrich, Sarah Sumner, Adam Gaines, and Robert Leavitt
Prevalence of Chronic Kidney Disease in Type 1 Diabetes Among Adults in the U.S., Peter Rossing, Per-Henrik Groop, Rakesh Singh, Robert Lawatscheck, and Katherine Tuttle
First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors, Rachel Sanborn
Two-Year Outcomes of Prostatic Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: An International, Multicenter, Prospective Study., Marc R Sapoval, Shivank Bhatia, Carole Déan, Antonio Rampoldi, Francisco César Carnevale, Clare Bent, Charles R Tapping, Simone Bongiovanni, Jeremy Taylor, Jayson S Brower, Michael Rush, Justin P McWilliams, Mark W Little, and PROstate Study Investigators
Association of mental health-related patient reported outcomes with blood pressure in adults and children with primary proteinuric glomerulopathies., Matthew Schuchman, Tammy M Brady, Dorey A Glenn, Katherine Tuttle, Gabriel Cara-Fuentes, Rebecca V Levy, Agustin Gonzalez-Vicente, Fadhl M Alakwaa, Tarak Srivastava, and Christine B Sethna
Management of Gastroschisis: Timing of Delivery, Antibiotic Usage, and Closure Considerations (A Systematic Review From the American Pediatric Surgical Association Outcomes & Evidence Based Practice Committee)., Mark B Slidell, Jarod P McAteer, Doug Miniati, Stig Sømme, Derek Wakeman, Kristy Rialon, Don Lucas, Alana Beres, Henry Chang, Brian Englum, Akemi Kawaguchi, Katherine Gonzalez, Elizabeth Speck, Gustavo Villalona, Afif Kulaylat, Rebecca Rentea, Yasmine Yousef, Sarkis Darderian, Shannon Acker, Shawn St Peter, Lorraine Kelley-Quon, Robert Baird, and Joanne Baerg
Developing immune therapies for prevention in breast cancer, Sasha Stanton
Moderator and Session Chair: Session 1: Loco-Regional Therapy in Breast Cancer, Sasha Stanton
Factors Related to Intent to Stay Among Acute Care Health Professionals, Danell Stengem, Alison Smock, Ashley Doherty, Dana Kopp, Karen Colorafi, and Teresa Rangel
Global High-Consequence Infectious Disease Readiness and Response: An Inventory of High-Level Isolation Units., Katie L Stern, Lauren M Sauer, Christa Arguinchona, Jake Dunning, Wael ElRayes, Poh Lian Lim, Shawn Vasoo, and Jocelyn J Herstein
Erratum to "Discussion to: del Nido versus blood cardioplegia in cardiac surgery: A multicenter analysis of over 40,000 patients" [The Journal of Thoracic and Cardiovascular Surgery Volume 168, Issue 6, December 2024, Pages 1698-1700]., James W Stewart, Matthew Forrester, and Robert B Hawkins
Perceived Moral Distress among Patient-facing Healthcare Professionals during the COVID-19 pandemic, Sarah Sumner, Karen Colorafi, and Teresa Rangel
Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study., Zoe Swank, Ella Borberg, Yulu Chen, Yasmeen Senussi, Sujata Chalise, Zachary Manickas-Hill, Xu G Yu, Jonathan Z Li, Galit Alter, Timothy J Henrich, J Daniel Kelly, Rebecca Hoh, Sarah A Goldberg, Steven G Deeks, Jeffrey N Martin, Michael J Peluso, Aarthi Talla, Xiaojun Li, Peter Skene, Thomas F Bumol, Troy R Torgerson, Julie L Czartoski, M Juliana McElrath, Elizabeth W Karlson, David R Walt, RECOVER consortium authors, and Katherine Tuttle (RECOVER consortium authors)
Case Report: A Nurses Experience with a Surgical Site Infection (SSI); Lessons from the Frontlines, Anna Tabor, Rachel Tommeraasen, and Joshua E Drumm
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today., Howard Trachtman, Hailey Desmond, Amanda L Williams, Laura H Mariani, Sean Eddy, Wenjun Ju, Laura Barisoni, Heather K Ascani, Wendy R Uhlmann, Cathie Spino, Lawrence B Holzman, John R Sedor, Crystal Gadegbeku, Lalita Subramanian, Chrysta C Lienczewski, Tina Manieri, Scott J Roberts, Debbie S Gipson, Matthias Kretzler, NEPTUNE investigators, and Katherine Tuttle (NEPTUNE investigators)
Past, Present, and Future of Cellular Immunotherapy, Eric Tran
Second Malignant Neoplasms Following Treatment for Hepatoblastoma: An International Report and Review of the Literature., Angela Trobaugh-Lotrario, Kenichiro Watanabe, Allison F O'Neill, Bozenna Dembowska-Bagińska, Beate Häberle, Andrew Murphy, Eiso Hiyama, Piotr Czauderna, Rebecka L Meyers, Max Langham, and James Feusner
Journal names its 25 People of Influence in 2025, Katherine Tuttle (author mention)
379. SGLT Inhibitors: The Biology of SGLT Inhibition with Dr. Katherine Tuttle, Katherine Tuttle
“Adjunctive Therapy in T1D”, Katherine Tuttle
“A Pinch of Salt – A Podcast by ERA”, Katherine Tuttle
“Benefits of Semaglutide on Chronic Kidney Disease Outcomes by Cardiovascular Status of Risk in the FLOW Trial.", Katherine Tuttle
“Benefits of semaglutide on chronic kidney disease outcomes by cardiovascular status or risk in the FLOW trial.", Katherine Tuttle
“Building your academic career portfolio”, Katherine Tuttle
“Cardiovascular-Kidney-Metabolic Syndrome, Katherine Tuttle
“Cases in Diabetes, Kidney, and Cardio-Renal-Metabolic Disease”, Katherine Tuttle
CKD screening for better kidney health: Why? Who? How? When?, Katherine Tuttle
Clinical and Mechanistic Effects of GLP-1 Receptor Agonists in CKD, Katherine Tuttle
“Diabetic Nephropathy 2024: Comprehensive Care for People with Diabetes Mellitus and Advanced Chronic Kidney Disease.", Katherine Tuttle
“DM and CKD Treatments: Which Treatment Should I Use for Different Populations?”, Katherine Tuttle
“Effects of Semaglutide on CKD in Patients with Type 2 Diabetes (FLOW)”, Katherine Tuttle
“Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.”, Katherine Tuttle
“FLOW: A new treatment paradigm for people with T2D and chronic kidney disease”, Katherine Tuttle
“FLOW: Benefits of Semaglutide on CKD by Cardiovascular Status or Risk.”, Katherine Tuttle
“FLOW Result: Summary and Clinical Implication, Katherine Tuttle
“FLOW: Semaglutide scores big in diabetic patients with CKD”, Katherine Tuttle
“ GLP1-RA in CKD”, Katherine Tuttle
GLP-1 Receptor Agonists for CKD in Diabetes and Beyond…, Katherine Tuttle
“GLP-1 Receptor Agonists for CKD in Diabetics and Beyond”, Katherine Tuttle
“Glycemic Management in Persons with Diabetes and CKD”, Katherine Tuttle
“Going with the FLOW: Understanding the renal effects of GLP-1RA Therapy”, Katherine Tuttle
Helio “Aldosterone inhibitor BI 690517 reduced albuminuria when combined with SGLT2 inhibitor”, Katherine Tuttle
Horizons-EASD eLearning, Katherine Tuttle
“How GLP1 receptor agonist evolved from weight management drug to kidney protective therapy”, Katherine Tuttle
“How Will the Incretin Data “FLOW” into Practice?”, Katherine Tuttle
“ Key considerations for tailoring treatment approaches for diabetic patients with chronic kidney disease", Katherine Tuttle
“Kidney Compass Podcast with Drs. Neuen/Wadhwani & Tuttle, Katherine Tuttle
“Kidney Disease and Obesity”, Katherine Tuttle
“Kidney Health for All: Advancing equitable access to care and optimal medication practice”, Katherine Tuttle
“Kidney Week 2024 Press Conference”, Katherine Tuttle
“Kidney Week 2024 Video Interview”, Katherine Tuttle
“Landmark studies”, Katherine Tuttle
“Miracle weight-loss drugs could halt kidney disease too”, Katherine Tuttle
"National Academies Workshop – Preparing the Future Workforce in Drug andResearch Development", Katherine Tuttle
National Geographic Interview feature article, Katherine Tuttle
“Navigating the Sea Change of CKD Treatment in Diabetes”, Katherine Tuttle
“Nephrology Times Interview”, Katherine Tuttle
“New study shows Ozempic lowers kidney disease”, Katherine Tuttle
“New use for Ozempic”, Katherine Tuttle
“Ozempic cuts risk in kidney disease”, Katherine Tuttle
“Ozempic cuts risk of chronic kidney disease complications, study finds””, Katherine Tuttle
“Ozempic keeps wowing: trial data show benefits for kidney disease”, Katherine Tuttle
“Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds", Katherine Tuttle
Plenary - “Kidney Health and CKD Prevention Herald a Sea Change in Nephrology”, Katherine Tuttle
Research Development., Katherine Tuttle
“Sea Change in CKD”, Katherine Tuttle
“Semaglutide cuts kidney failure and death in diabetes”, Katherine Tuttle
“Semaglutide Reduced Risks of Major Kidney Outcomes Irrespective of CKD Severity in the FLOW Trial”, Katherine Tuttle
